DIGILITI MONEY (NASDAQ: DGLT) and Veracyte (NASDAQ:VCYT) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

Valuation and Earnings

This table compares DIGILITI MONEY and Veracyte’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
DIGILITI MONEY $9.03 million 1.14 -$6.89 million N/A N/A
Veracyte $71.70 million 3.81 -$20.10 million ($0.80) -10.09

DIGILITI MONEY has higher revenue, but lower earnings than Veracyte.

Institutional & Insider Ownership

4.8% of DIGILITI MONEY shares are held by institutional investors. Comparatively, 63.6% of Veracyte shares are held by institutional investors. 50.9% of DIGILITI MONEY shares are held by company insiders. Comparatively, 13.4% of Veracyte shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and target prices for DIGILITI MONEY and Veracyte, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIGILITI MONEY 0 0 1 0 3.00
Veracyte 0 0 5 0 3.00

DIGILITI MONEY currently has a consensus price target of $6.00, suggesting a potential upside of 473.39%. Veracyte has a consensus price target of $13.00, suggesting a potential upside of 61.09%. Given DIGILITI MONEY’s higher probable upside, research analysts clearly believe DIGILITI MONEY is more favorable than Veracyte.

Profitability

This table compares DIGILITI MONEY and Veracyte’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DIGILITI MONEY -147.73% N/A -199.21%
Veracyte -35.64% -53.58% -29.07%

Summary

Veracyte beats DIGILITI MONEY on 6 of the 10 factors compared between the two stocks.

DIGILITI MONEY Company Profile

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

Veracyte Company Profile

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. The Company’s commercial solution, the Afirma Thyroid fine needle aspiration (FNA) Analysis, centers on the Afirma Gene Expression Classifier (GEC). The Afirma GEC is offered directly or as part of a solution that also includes cytopathology. The Company operates in the pulmonology diagnostics market. It offers Percepta Bronchial Genomic Classifier, a genomic test to resolve ambiguity in lung cancer diagnosis. It also offers the Envisia Genomic Classifier, which is designed to help in the assessment of patients suspected to have idiopathic pulmonary fibrosis.

Receive News & Stock Ratings for DIGILITI MONEY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIGILITI MONEY and related stocks with our FREE daily email newsletter.